Clinical Study Of Migraine Evolution
Completed
- Conditions
- Migraine Headache
- Registration Number
- NCT00460005
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
Understanding the speed at which migraine headaches develop is of importance to patients. Determining the proportions in which different headache pain build-up occurs, may provide health care practitioners with valuable information with which to prescribe the most appropriate treatment. Patients who experience a slow pain build-up may gain more benefit from medications which have a slow onset of effect, high tolerability and long action. Conversely, medications with a rapid onset of effect may be of greater benefit to patients who experience rapid onset of migraine pain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
- Subject is outpatient.
- Subject has a diagnosis of migraine with/without aura according to IHS criteria, of at least 1 years duration.
- Subject is able to comprehend the study procedures and to comply with study requirements.
Read More
Exclusion Criteria
- Subject has other chronic pain condition(s) not associated with migraine
- Subject is unable to understand the schedule/questionnaire.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
GSK Clinical Trials Call Centre
🇨🇦Montreal, Quebec, Canada